Drugs of abuse and psychiatric disorders: Neurobiological and clinical aspects

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 52, Issue , 2014, Pages 1-3

  Samaha, Anne Noël ^a   Potvin, Stéphane ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DOPAMINE; DOPAMINE 3 RECEPTOR; METHAMPHETAMINE;

ATTENTION DEFICIT DISORDER; BEHAVIOR CONTROL; COMORBIDITY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG ABUSE; EDITORIAL; HUMAN; MENTAL DISEASE; NERVE CELL NETWORK; NERVE CONDUCTION; NEUROBIOLOGY; NONHUMAN; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SMOKING; ADDICTION; ANIMAL;

ANIMALS; HUMANS; MENTAL DISORDERS; NEUROBIOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 84899660192     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.03.012     Document Type: Editorial

References (18)

1. Bornovalova M.A., Lejuez C.W., Daughters S.B., Zachary Rosenthal M., Lynch T.R. Impulsivity as a common process across borderline personality and substance use disorders. Clin Psychol Rev 2005, 25:790-812.
2. Ghazzaoui R., Abi-Dargham A. Imaging dopamine transmission parameters in cannabis dependence. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:28-32. (this issue).
3. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J., Pickering R.P. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004, 61:361-368.
4. Hasin D.S., Stinson F.S., Ogburn E., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007, 64:830-842.
5. Huizink A.C. Prenatal cannabis exposure and infant outcomes: Overview of studies. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:45-52. (this issue).
6. Kollins SH, Adcock RA. ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: Implications for smoking and nicotine dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2014, 52:70-78. (this issue).
7. McCarthy E., Petrakis I. Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorder. CNS Drugs 2010, 24:997-1007.
8. Oleson E.B., Cachope R., Fitoussi A., Cheer J.F. Tales from the dark side: Do neuromodulators of drug withdrawal require changes in endocannabinoid tone?. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:17-23. (this issue).
9. O'Tuathaigh CM, Gantois I, Waddington JL Genetic dissection of the psychotomimetic effects of cannabinoid exposure. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:33-40. (this issue).
10. Payer D., Balasubramaniam G., Boileau I. What is the role of the D3 receptor in addiction? A mini review of PET studies with [C]-(+)-PHNO. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:4-8. (this issue).
11. Pettinati H.M., O'Brien C.P., Dundon W.D. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry 2013, 170:23-30.
12. Pickard H., Fazel S. Substance abuse as a risk factor for violence in mental illness: some implications for forensic psychiatric practice and clinical ethics. Curr Opin Psychiatry 2013, 26:349-354.
13. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith B.J., Judd L.L., et al. Comorbidity of mental health disorders with alcohol and other drug abuse. JAMA 1990, 264:2511-2518.
14. Rubino T., Parolaro D. Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:41-44. (this issue).
15. Samaha A.N. Can antipsychotic treatment contribute to drug addiction in schizophrenia?. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:9-16. (this issue).
16. Swendsen J., Conway K.P., Degenhardt L., Glantz M., Jin R., Merikangas K.R., et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010, 105:1117-1128.
17. Willens T.E., Morrison N.R. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry 2011, 24:280-285.
18. Ziedonis D.M., Smelson D., Rosenthal R.N., Batki S.L., Green A.I., Henry R.J., et al. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract 2005, 11:315-339.